MedTrace Logo

Cross-cultural Adaptation to the Spanish Population and Validation of the BESTest and Mini-BESTest

NCT04052087 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 104

Last updated 2022-07-27

No results posted yet for this study

Summary

Due to brain damage acquired (BDA), is often difficulty in gait and balance alterations, as problems that patients designated as the most disabling. It is essential to an effective assessment of the balance.

Objective: The purpose of the present project adapt and verify the validity of the scale MiniBESTest, version of the BESTest, in patients with BDA in subacute and chronic stage, since that is postulated as a brief tool and covering the peculiarities of the specific alterations of the patient after suffering brain damage.

Methodology: Between September 2019 and December 2020 will be transcultural adaptation to the BDA and validation of psychometric scale Mini-BESTest in three phases. 60 subjects who receive treatment in the center of attention State reference to brain damage (CEADAC), together with the comunidad de Madrid private neurological rehabilitation centers will be recruited.

Results: validity and reliability parameters shall be calculated by means of descriptive statistics for each item of the scales and the set of scale score. You will also analyze the internal consistency using Cronbach's alpha, the interclass correlation coefficient will be used to determine the reliability, and the items will be scanned with the Pearson coefficient: \> 0.20, among other parameters.

Conditions

  • Brain Damage

Sponsors & Collaborators

  • University of Castilla-La Mancha

    collaborator OTHER

  • University of Alcala

    collaborator OTHER

  • Centro de Referencia Estatal de Atención Al Daño Cerebral

    lead OTHER

Principal Investigators

  • Cristina Lirio Romero, PhD · University of Castilla-La Mancha

Eligibility

Min Age
16 Years
Max Age
54 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-15
Primary Completion
2022-01-20
Completion
2022-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04052087 on ClinicalTrials.gov